| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$90 |
Notification regarding unquoted securities - GCM
|
28 Oct 2024 9:11AM |
$0.003 |
$0.035 |
risen by
1,300%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,323 |
Net Tangible Asset Backing - 25 October 2024
|
28 Oct 2024 9:11AM |
$2.320 |
$2.760 |
risen by
18.97%
|
|
| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$90 |
Application for quotation of securities - GCM
|
28 Oct 2024 9:11AM |
$0.003 |
$0.035 |
risen by
1,300%
|
|
| Beonic Ltd (BEO) ORDINARY FULLY PAID |
Information Technology |
$20 |
Notice of Annual General Meeting/Proxy Form
|
28 Oct 2024 9:11AM |
$0.025 |
$0.280 |
risen by
1,020%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$33 |
Quarterly Activities Report
|
28 Oct 2024 9:11AM |
$0.062 |
$0.088 |
risen by
41.94%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly revenue of $3.5 million, up 7% year-on-year.
- Positive operating cash flow for the second consecutive quarter.
- Revenue margin improved to 3.0%, up from 2.7% in the previous corresponding period.
- Net operating costs reduced by 28% compared to the previous year.
- Platform originations exceeded $40 million, up 25% year-on-year.
- Cash on hand increased to $15.3 million, providing financial flexibility.
- Exploration of growth opportunities, including a new Retail Private Credit Fund.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$276 |
Project PARASOL Update & Medical Advisory Board Appointment
|
28 Oct 2024 9:10AM |
$0.420 |
$0.460 |
risen by
9.52%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- The PARASOL working group confirmed eGFR as a surrogate endpoint for FDA approval.
- There is strong evidence supporting the relationship between proteinuria reduction and kidney disease progression.
- A range of proteinuria endpoints may be acceptable for FDA approval for Dimerix's ACTION3 clinical trial.
- Dr. Laura Mariani has been appointed to the Dimerix Medical Advisory Board.
- 129 patients have been randomized in the ACTION3 Phase 3 clinical trial.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Objective Corporation Limited (OCL) ORDINARY FULLY PAID |
Information Technology |
$1,854 |
Notice of General Meeting/Proxy Form
|
28 Oct 2024 9:10AM |
$15.500 |
$19.390 |
risen by
25.10%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$33 |
Quarterly Appendix 4C Cash Flow Report
|
28 Oct 2024 9:10AM |
$0.062 |
$0.088 |
risen by
41.94%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Current quarter cash flow from operating activities was $299,000.
- Total cash and cash equivalents at the end of the period was $15,254,000.
- Net cash from investing activities amounted to $1,671,000.
- Payments to related parties totaled $199,000.
- Loan facilities of $81.326 million were reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Taruga Minerals Limited (TAR) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - TAR
|
28 Oct 2024 9:09AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Saturn Metals Limited (STN) ORDINARY FULLY PAID |
Materials |
$202 |
Significant Drill Results Apollo Hill Gold Project
|
28 Oct 2024 9:09AM |
$0.295 |
$0.440 |
risen by
49.15%
|
|
STN - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling results show potential to grow the Apollo Hill Mineral Resource.
- Notable intersections include 12m @ 2.98g/t Au and 34m @ 1.29g/t Au.
- All holes reported material intercepts above Apollo Hill cut-off grade.
- Results used for a near-term upgrade of the existing 1.84Moz resource.
- 38,000m of additional drilling is scheduled.
- Drilling highlights continuity of mineralization at depth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QX Resources Limited (QXR) ORDINARY FULLY PAID |
Materials |
$5 |
Proposed issue of securities - QXR
|
28 Oct 2024 9:09AM |
$0.006 |
$0.004 |
fallen by
33.33%
|
|
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$237 |
September 2024 Quarterly Report and Appendix 5B
|
28 Oct 2024 9:09AM |
$2.500 |
$2.100 |
fallen by
16%
|
|
BRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Major Exploration Success at Monte Alto Project
- Highest-grade rare earth intercepts recorded with grades up to 39.1% TREO
- Longest mineralised intercept reported at 75.8m at 13.8% TREO
- Discovery of ultra-high grade heavy rare earth mineralisation at Monte Alto East
- Development MOU signed with Bahia Government to support Rocha da Rocha province
- Expansion of exploration area at Monte Alto to over 12 km²
- Exploration expenditures for the quarter totaled A$7,286,000
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QX Resources Limited (QXR) ORDINARY FULLY PAID |
Materials |
$5 |
Placement to Raise $1 million
|
28 Oct 2024 9:09AM |
$0.006 |
$0.004 |
fallen by
33.33%
|
|
QXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Firm commitments received for a two-tranche placement to raise $1 million.
- 200 million shares will be issued at $0.005 per share.
- Proceeds will be used towards Queensland gold projects and Western Australian iron ore and lithium projects.
- Strong bids received with participation from institutional and sophisticated shareholders.
- $150,000 participation by directors pending shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$269 |
Commencement of major drilling program
|
28 Oct 2024 9:08AM |
$0.620 |
$0.635 |
risen by
2.42%
|
|
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$35 |
Investor webinar invitation and investor presentation
|
28 Oct 2024 9:08AM |
$0.145 |
$0.115 |
fallen by
20.69%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$68 |
Proposed issue of securities - NYR
|
28 Oct 2024 9:07AM |
$0.140 |
$0.285 |
risen by
103.57%
|
|
| Advanced Health Intelligence Ltd (AHI) ORDINARY FULLY PAID |
Health Care |
$26 |
AHI Granted US Patent
|
28 Oct 2024 9:05AM |
$0.092 |
$0.092 |
fallen by
0%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$22 |
Proposed issue of securities - OSL
|
28 Oct 2024 9:05AM |
$0.013 |
$1.165 |
risen by
8,861.54%
|
|
| Arizona Lithium Limited (AZL) ORDINARY FULLY PAID |
Materials |
$43 |
Flow Testing at Pad 1 Completed
|
28 Oct 2024 9:05AM |
$0.017 |
$0.008 |
fallen by
52.94%
|
|
AZL - Price-sensitive ASX Announcement
Full Release
Key Points
- Flow testing of Well #3 at Pad #1 has been completed.
- Results of the Completions work including grade and flow rates will be released next month.
- The company will convert this well into a future production well at Pad #1.
- Arizona Lithium has recently announced the completion of drilling on Pad #2 and the clearing of the well pad at Pad #3.
- Each pad has an estimated Net Present Value (NPV) of approximately US$150 million.
- Arizona Lithium raised A$11 million in non-dilutive capital from a non-core acreage sale.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$22 |
OSL completes $7 M Placement and announces $1 M SPP
|
28 Oct 2024 9:05AM |
$0.013 |
$1.165 |
risen by
8,861.54%
|
|
OSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of $7 million placement for commercialisation activities.
- Funding for clinical trials and investment in Sydney manufacturing facility.
- SPP offer to raise up to $1 million for eligible shareholders.
- Market expansion targets include Switzerland, Chile, and South Korea.
- Chairman Douglas Cubbin committed approximately $100,000 to the placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$68 |
Optiscan Participates in Major US Industry Events
|
28 Oct 2024 9:04AM |
$0.160 |
$0.082 |
fallen by
48.75%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$771 |
Net Tangible Asset Backing
|
28 Oct 2024 9:03AM |
$2.350 |
$2.390 |
risen by
1.70%
|
|
| Larvotto Resources Limited (LRV) ORDINARY FULLY PAID |
Materials |
$348 |
Underwriting Agreement for listed LRVO options
|
28 Oct 2024 9:03AM |
$0.690 |
$0.735 |
risen by
6.52%
|
|
LRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Underwriting Agreement secures $4.5 million for Larvotto Resources.
- Funds will come from the exercise of ASX-listed Larvotto options (LRVO).
- There are approximately 14.9 million LRVO options outstanding.
- Options have a strike price of $0.30 and expire on 1 December 2024.
- The funding will support development at Hillgrove gold-antimony project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
Completion of Healthy Chef Acquisition
|
28 Oct 2024 9:02AM |
$0.004 |
$0.017 |
risen by
325%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities Report and Appendix 5B
|
28 Oct 2024 9:02AM |
$0.096 |
$0.081 |
fallen by
15.63%
|
|
AXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Axel REE Limited successfully listed on the ASX on 23 July 2024.
- The IPO raised $13.3 million, enabling multiple exploration programs.
- Caladão Project has a 20,000m drill program underway to investigate REE mineralization.
- Caldas Project initiated a drilling program adjacent to significant REE discoveries.
- The company is fully funded with $11.2 million cash at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
